Trials that use: Fisher exact test
New to this method? Read the tutorial →
5,849 results
- ICT-HCTIndependent statistical analysis of Chemotherapy in Treating Patients With Myelodysplastic Syndrome Before Donor Stem Cell Transplant: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Id-KLH Vaccine + T Cells in Subjects With Myeloma Undergoing Transplant: Complete Statistical AnalysisIndependent statistical analysis of Id-KLH Vaccine + T Cells in Subjects With Myeloma Undergoing Transplant: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- ID11-56Independent statistical analysis of An Evaluation of Marketed Contact Lens Disinfectant Systems on Eyelid Tissues: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- IDEAIndependent statistical analysis of Ivermectin, Aspirin, Dexamethasone and Enoxaparin as Treatment of Covid 19: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04425863).
- Idelalisib in Combination With Rituximab for Previously Untreated Follicular Lymphoma and Small Lymphocytic Lymphoma: Complete Statistical AnalysisIndependent statistical analysis of Idelalisib in Combination With Rituximab for Previously Untreated Follicular Lymphoma and Small Lymphocytic Lymphoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- IdeS in Asymptomatic Antibody-Mediated Thrombotic Thrombocytopenic Purpura (TTP) Patients: Complete Statistical AnalysisIndependent statistical analysis of IdeS in Asymptomatic Antibody-Mediated Thrombotic Thrombocytopenic Purpura (TTP) Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02854059).
- IFUMIndependent statistical analysis of Efficacy, Safety, Tolerability of Gefitinib as 1st Line in Caucasian Patients With EGFR Mutation Positive Advanced NSCLC: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- IHAIndependent statistical analysis of Efficacy, Safety and Tolerability of Icatibant for the Treatment of HAE: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- IKEEGIndependent statistical analysis of EEG Changes With Guided Online Meditation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03459690).
- IL-11 in Women With Von Willebrand Disease and Refractory Menorrhagia: Complete Statistical AnalysisIndependent statistical analysis of IL-11 in Women With Von Willebrand Disease and Refractory Menorrhagia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00524342).
- IL-15 Super Agonist ALT-803 to Treat Relapse Of Hematologic Malignancy After Allogeneic SCT: Complete Statistical AnalysisIndependent statistical analysis of IL-15 Super Agonist ALT-803 to Treat Relapse Of Hematologic Malignancy After Allogeneic SCT: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- IMIndependent statistical analysis of Acetic Acid Chromoendoscopy to Judge Gastric Intestinal Metaplasia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01499576).
- Image Evaluation of Philips Philips MammoDiagnost DR Full Field Digital Mammography System (FFDM): Complete Statistical AnalysisIndependent statistical analysis of Image Evaluation of Philips Philips MammoDiagnost DR Full Field Digital Mammography System (FFDM): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Image Guidance for Improved Vessel Cannulation in Pediatric Patients: Complete Statistical AnalysisIndependent statistical analysis of Image Guidance for Improved Vessel Cannulation in Pediatric Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04031495).
- Image-Guided Navigation for High Dose Rate Temporary Interstitial Brachytherapy in the Palliative Management of Previously Treated Tumors of the Spine and Pelvis: Complete Statistical AnalysisIndependent statistical analysis of Image-Guided Navigation for High Dose Rate Temporary Interstitial Brachytherapy in the Palliative Management of Previously Treated Tumors of the Spine and Pelvis: primary endpoint results, effect estimate with…
- Image-Guided Radiosurgery or Stereotactic Body Radiation Therapy in Treating Patients With Localized Spine Metastasis: Complete Statistical AnalysisIndependent statistical analysis of Image-Guided Radiosurgery or Stereotactic Body Radiation Therapy in Treating Patients With Localized Spine Metastasis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- IMAGINEIndependent statistical analysis of Study of Innovative Multimodal Imaging Biomarkers to Predict Anatomical Outcome in Naive Patients With wAMD Treated With Brolucizumab.: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- IMAGINE 8Independent statistical analysis of A Study to Compare the Effect of a Double Dose of Two Long-acting Insulin Therapies in Participants With Type 2 Diabetes: primary endpoint results, effect estimate with confidence…
- Imaging in MGUS, SMM and MM: Complete Statistical AnalysisIndependent statistical analysis of Imaging in MGUS, SMM and MM: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01237054).
- iMALTIndependent statistical analysis of Improving Medication Adherence in Adolescents Who Had a Liver Transplant: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03691220).
- IMARA-SA pilotIndependent statistical analysis of A Comprehensive HIV Prevention Package for South African Adolescent Girls and Young Women: IMARA SA: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- iMATRIXcobiIndependent statistical analysis of Safety and Pharmacokinetics of Cobimetinib in Pediatric and Young Adult Participants With Previously Treated Solid Tumors: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Imiquimod for Breast Cancer Patients With Chest Wall Recurrence or Skin Metastases: Complete Statistical AnalysisIndependent statistical analysis of Imiquimod for Breast Cancer Patients With Chest Wall Recurrence or Skin Metastases: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Imiquimod, Fluorouracil, or Observation in Treating HIV-Positive Patients With High-Grade Anal Squamous Skin Lesions: Complete Statistical AnalysisIndependent statistical analysis of Imiquimod, Fluorouracil, or Observation in Treating HIV-Positive Patients With High-Grade Anal Squamous Skin Lesions: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Immediate Loading and Fully Guided Surgery: Single Implants: Complete Statistical AnalysisIndependent statistical analysis of Immediate Loading and Fully Guided Surgery: Single Implants: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04061694).
- Immediate Postplacental IUD Insertion: Complete Statistical AnalysisIndependent statistical analysis of Immediate Postplacental IUD Insertion: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02169869).
- Immediate Versus Delayed Insertion of the Copper Intrauterine Device (IUD) After Medication Abortion: Complete Statistical AnalysisIndependent statistical analysis of Immediate Versus Delayed Insertion of the Copper Intrauterine Device (IUD) After Medication Abortion: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- IMmotion151Independent statistical analysis of A Study of Atezolizumab in Combination With Bevacizumab Versus Sunitinib in Participants With Untreated Advanced Renal Cell Carcinoma (RCC): primary endpoint results, effect estimate with confidence interval, sample-size…
- IMMULAB – Immunotherapy With Pembrolizumab in Combination With Local Ablation in Hepatocellular Carcinoma (HCC): Complete Statistical AnalysisIndependent statistical analysis of IMMULAB - Immunotherapy With Pembrolizumab in Combination With Local Ablation in Hepatocellular Carcinoma (HCC): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Immune Response Induced by a Vaccine Against Group B Streptococcus and Safety in Pregnant Women and Their Offsprings: Complete Statistical AnalysisIndependent statistical analysis of Immune Response Induced by a Vaccine Against Group B Streptococcus and Safety in Pregnant Women and Their Offsprings: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- Immunity to Serotype 19A Streptococcus Pneumoniae in Children Vaccinated With PCV10: Complete Statistical AnalysisIndependent statistical analysis of Immunity to Serotype 19A Streptococcus Pneumoniae in Children Vaccinated With PCV10: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Immunization of Children Previously Primed With GSK Pneumococcal Vaccine GSK1024850A and of Unprimed Children in Mali: Complete Statistical AnalysisIndependent statistical analysis of Immunization of Children Previously Primed With GSK Pneumococcal Vaccine GSK1024850A and of Unprimed Children in Mali: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Immunization of Children Previously Primed With GSK Pneumococcal Vaccine GSK1024850A and of Unprimed Children in Nigeria: Complete Statistical AnalysisIndependent statistical analysis of Immunization of Children Previously Primed With GSK Pneumococcal Vaccine GSK1024850A and of Unprimed Children in Nigeria: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Immuno-nutrition Supplementation in Haemodialysis: Complete Statistical AnalysisIndependent statistical analysis of Immuno-nutrition Supplementation in Haemodialysis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05700851).
- Immunogenicity & Reactogenicity of Boostrix 10 Years After Previous Booster Vaccination.: Complete Statistical AnalysisIndependent statistical analysis of Immunogenicity & Reactogenicity of Boostrix 10 Years After Previous Booster Vaccination.: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Immunogenicity & Safety of Hepatitis A Vaccine Co-admin With a Measles/Mumps/Rubella & a Varicella Vaccine in Children: Complete Statistical AnalysisIndependent statistical analysis of Immunogenicity & Safety of Hepatitis A Vaccine Co-admin With a Measles/Mumps/Rubella & a Varicella Vaccine in Children: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Immunogenicity and Safety of a Booster Dose of an Investigational Quadrivalent Meningococcal Conjugate Vaccine: Complete Statistical AnalysisIndependent statistical analysis of Immunogenicity and Safety of a Booster Dose of an Investigational Quadrivalent Meningococcal Conjugate Vaccine: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Immunogenicity and Safety of a Purified Vero Rabies Vaccine: Complete Statistical AnalysisIndependent statistical analysis of Immunogenicity and Safety of a Purified Vero Rabies Vaccine: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03145766).
- Immunogenicity and Safety of BPZE1 Intranasal Pertussis Vaccine in Healthy School-age Children: Complete Statistical AnalysisIndependent statistical analysis of Immunogenicity and Safety of BPZE1 Intranasal Pertussis Vaccine in Healthy School-age Children: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Immunogenicity and Safety of Concomitant Administration of RotaTeq™ (V260) and the Diphtheria, Tetanus, Pertussis and Inactivated Poliovirus Vaccine (DTP-IPV) in Healthy Japanese Infants (V260-060): Complete Statistical AnalysisIndependent statistical analysis of Immunogenicity and Safety of Concomitant Administration of RotaTeq™ (V260) and the Diphtheria, Tetanus, Pertussis and Inactivated Poliovirus Vaccine (DTP-IPV) in Healthy Japanese Infants (V260-060): primary endpoint results, effect…
- Immunogenicity and Safety of Live Attenuated Influenza Vaccine (Flumist) Administered by Nasal and Sublingual Route: Complete Statistical AnalysisIndependent statistical analysis of Immunogenicity and Safety of Live Attenuated Influenza Vaccine (Flumist) Administered by Nasal and Sublingual Route: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Immunogenicity and Safety of Meningococcal ACWY Conjugate Vaccine in Healthy Subjects From 2 to 18 Years in Taiwan: Complete Statistical AnalysisIndependent statistical analysis of Immunogenicity and Safety of Meningococcal ACWY Conjugate Vaccine in Healthy Subjects From 2 to 18 Years in Taiwan: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- Immunogenicity and Safety of PrepandrixTM in Korean Subjects Aged 18 to 60 Years Old: Complete Statistical AnalysisIndependent statistical analysis of Immunogenicity and Safety of PrepandrixTM in Korean Subjects Aged 18 to 60 Years Old: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Immunogenicity and Safety Study of a Vaccine Against Lyme Borreliosis, in Healthy Adults Aged 18 to 65 Years. Randomized, Controlled, Observer-blind Phase 2 Study.: Complete Statistical AnalysisIndependent statistical analysis of Immunogenicity and Safety Study of a Vaccine Against Lyme Borreliosis, in Healthy Adults Aged 18 to 65 Years. Randomized, Controlled, Observer-blind Phase 2 Study.: primary endpoint results, effect…
- Immunogenicity and Safety Study of Booster Dose of GSK Biologicals’ IPV (Poliorix™) and DTPa/Hib (Infanrix+Hib™) Vaccine: Complete Statistical AnalysisIndependent statistical analysis of Immunogenicity and Safety Study of Booster Dose of GSK Biologicals' IPV (Poliorix™) and DTPa/Hib (Infanrix+Hib™) Vaccine: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals’ Meningococcal Conjugate Vaccine (GSK134612) When Co-administered With Boostrix® in Subjects Between 11 and 25 Years of Age: Complete Statistical AnalysisIndependent statistical analysis of Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Meningococcal Conjugate Vaccine (GSK134612) When Co-administered With Boostrix® in Subjects Between 11 and 25 Years of Age: primary endpoint results,…
- Immunogenicity and Safety Study of GSK Biologicals’ Meningococcal Vaccine GSK 134612 Versus Menactra® in Healthy Adolescents/Adults: Complete Statistical AnalysisIndependent statistical analysis of Immunogenicity and Safety Study of GSK Biologicals' Meningococcal Vaccine GSK 134612 Versus Menactra® in Healthy Adolescents/Adults: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Immunogenicity and Safety Study of Rotarix TM in Taiwanese Infants Who Received Hepatitis B Immunoglobulin After Birth.: Complete Statistical AnalysisIndependent statistical analysis of Immunogenicity and Safety Study of Rotarix TM in Taiwanese Infants Who Received Hepatitis B Immunoglobulin After Birth.: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Immunogenicity and Safety Study to Assess Influenza Vaccine Formulated With Haemagglutinin (HA) Antigen From Two Different Suppliers: Complete Statistical AnalysisIndependent statistical analysis of Immunogenicity and Safety Study to Assess Influenza Vaccine Formulated With Haemagglutinin (HA) Antigen From Two Different Suppliers: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Immunogenicity of Fluzone HD,A High Dose Influenza Vaccine, In Children With Cancer or HIV: Complete Statistical AnalysisIndependent statistical analysis of Immunogenicity of Fluzone HD,A High Dose Influenza Vaccine, In Children With Cancer or HIV: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…